Ellipsys Medical, Inc.
About Ellipsys Medical, Inc.
Ellipsys Medical, Inc. is a medical device company based in San Clemente, California, focused on vascular access solutions. The company acquired the Ellipsys Vascular Access System from Medtronic and is preparing a phased reintroduction to the US and select international markets in 2026. The system is an ultrasound-guided, single-catheter device that creates arteriovenous fistulas percutaneously without open surgery or permanent implants. It received FDA clearance in 2018 and is supported by peer-reviewed studies and clinical experience.
- 🔗 Ellipsys Medical Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 CVS, Salesforce back Ellipsis Health's $45M series A raise
- 🔗 Ellipsys Vascular Access System Receives CE Mark Approval - Medical Design and Outsourcing
- 🔗 Ellipsys Vascular Access System to Return to Market - Endovascular Today
- 🔗 Ellipsys vascular access system to return to US market in 2026 - Vascular News
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Ellipsys Medical, Inc. raised $8,094,655 through a private placement.
- Company is reintroducing the Ellipsys Vascular Access System to the US market in 2026 after acquiring it from Medtronic.
- The system enables minimally invasive AV fistula creation using a single-catheter ultrasound-guided approach.
- Device previously held FDA clearance and has peer-reviewed clinical publications supporting its use.
Ask StreetZero about Ellipsys Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account